Loading…
Attending this event?
Tuesday, June 18 • 10:00am - 11:00am
#221: Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-24-572-L04-P; CME 1.00; RN 1.00

Improving access and minimizing burdens are critical to ensuring diverse representation in clinical trials. Panelists will discuss efforts to improve patient access to oncology clinical trials through streamlined protocols and decentralized elements.

Learning Objectives

Describe the impact of incorporating decentralized elements (DE) into oncology clinical trials (CTs) on data integrity, patient safety and regulatory approvals; Explain how DE elements increase patient access and recognize opportunities to implement DE; Identify ongoing barriers to implementing DE into CT protocols and solutions to address operational challenges in expanding access to care.

Chair

Suanna S. Bruinooge, MPH

Speaker

How Sponsors, CROs, and Sites Can Work Together
Craig H Lipset, MPH

Meta-Analysis of Trials During COVID
Joseph Unger, PhD, MS

Implementing Trials in Large Healthcare System
Ramya Thota


Speakers
avatar for Suanna Bruinooge

Suanna Bruinooge

Chief and Division Director, Research Strategy and Operations Center, American Society of Clinical Oncology, United States
Suanna Bruinooge, MPH, is the Chief and Division Director of Research Strategies and Collaborations in ASCO’s Center for Research and Analytics (CENTRA). CENTRA generates and analyzes oncology data to foster innovation in research and patient care and help develop evidence related... Read More →
avatar for Craig Lipset

Craig Lipset

Managing Partner, Clinical Innovation Partners, United States
Craig Lipset is an advisor, educator, advocate and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, providing advisory and board leadership with pharma, tech and investors. Craig is Co-Chair for the... Read More →
avatar for Ramya Thota

Ramya Thota

Associate Professor, Intermountain Medical Oncology - IMC, United States
Dr. Thota is a GI medical oncologist at Intermountain Health, Utah. She finished her subspecialty Hematology and Medical Oncology fellowship training from Vanderbilt University, Nashville, Tennessee. She receives research funding from American Cancer Society Clinician Scientist Development... Read More →
avatar for Joseph Unger

Joseph Unger

Associate Professor, Fred Hutchinson Cancer Center, United States
Dr. Joseph Unger is a biostatistician and health services researcher. He uses big data to understand more about cancer patients’ treatment outcomes and disparities, especially as they pertain to barriers to participating in clinical trials. He has been at the forefront of efforts... Read More →

Tuesday June 18, 2024 10:00am - 11:00am PDT
Room 6F San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  05: Patient-Focused Drug Dev, Forum |   02: ClinTrials -ClinOps, Forum